Business Context and Reporting Period
Company: Flotek Industries Inc.
Filing Date: November 14, 2001 (Reporting Date: October 23, 2001)
Event: Completion of a reverse merger with Chemical & Equipment Specialties, Inc. ("CESI") and a change of domicile from Alberta, Canada to Delaware.
On October 31, 2001, Flotek completed the merger with CESI. For accounting purposes, the transaction is treated as an acquisition of Flotek by CESI under the purchase method. Consequently, future financial statements will reflect the historical results of CESI, with Flotek's results incorporated only post-merger. The combined entity will report on a calendar year basis effective December 31, 2001.
Key Financial Metrics and Capital Structure
Capitalization and Equity:
- Shares Issued for Merger: 2,994,478 shares of common stock issued to CESI shareholders.
- Assumed Obligations: Employee stock options and contingent share issuance obligations totaling 117,524 shares.
- Preferred Stock Conversion: All preferred shares converted to common stock at $3.24 per share (post-split).
- Warrant Exercises: 536,141 warrants exercised at $3.60 per share (post-split), generating $1,930,106 in cash proceeds.
- Total Outstanding Shares: 4,850,696 shares (post-merger and post-split, excluding fractional share cash adjustments).
Reverse Stock Split: A 120-for-1 reverse stock split was implemented effective November 5, 2001, coinciding with the change in ticker symbol to "FLTK".
Financial Statements: The filing does not provide specific revenue, profit, or cash flow figures for the current period. Pro forma financial statements and historical financials for CESI are scheduled to be filed in an amended 8-K by January 14, 2002.
Material Changes Versus Prior Period
- Corporate Structure: Jurisdiction of incorporation changed from Alberta, Canada to Delaware, approved by 99.96% of voting shares.
- Accounting Basis: Shift from Flotek-centric reporting to CESI-centric reporting due to the reverse merger accounting treatment.
- Share Count: Significant reduction in share count due to the 120:1 reverse split, offset by new issuance for the merger and warrant exercises.
- Operations: Expansion into CESI's segments: specialty chemicals (cementing/stimulation) and equipment manufacturing (ISO 9001 certified).
Guidance, Outlook, and Risks
Management Commentary: The merger is intended to combine Flotek's capabilities with CESI's operations in the oilfield service industry. The combined company will focus on innovative cementing/stimulation chemicals and specialized equipment manufacturing.
Contingencies and Risks:
- Shareholder Lock-Up: Key shareholders have entered into a one-year lock-up agreement restricting the sale or transfer of common stock, subject to limited exceptions (private transfers and Rule 144).
- Regulatory Filings: Critical financial data (pro forma and acquired business statements) is pending and not yet available in this filing.
- Legal Indemnification: Shareholders have agreed to indemnify the company against liabilities arising from inaccuracies in their representations or failure to perform obligations under the reorganization agreement.
Investor Verification Checklist
- Pro Forma Financials: Verify the upcoming amended 8-K (due Jan 14, 2002) for combined revenue, earnings, and debt levels.
- Accounting Treatment: Confirm the specific asset revaluation and goodwill implications of the purchase method accounting.
- Shareholder Dilution: Review the final share count after fractional share cash payments are settled.
- Lock-Up Expirations: Monitor the one-year lock-up expiration date for major shareholders to assess future selling pressure.
- Operational Synergies: Evaluate the integration progress of Flotek's and CESI's oilfield service segments.